TNPSC Thervupettagam

Antibiotic Zosurabalpin

April 1 , 2024 266 days 453 0
  • Researchers have identified a new class of antibiotics with the potential to tackle a drug-resistant bacterium, Acinetobacter baumannii.
  • Zosurabalpin was found to be effective against CRAB (carbapenem-resistant Acinetobacter baumannii)-induced pneumonia and sepsis in mouse models.
  • A. baumannii inhibits a key process, transport of the molecule lipopolysaccharide (LPS), by inhibiting a complex of proteins.
  • This complex was essential for transporting LPS to the bacterial surface to create the outer-membrane structure of Gram-negative bacteria.
  • Zosurabalpin blocks LPS transport, and the abnormal build-up of LPS in the cell kills the bacterium.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories